Taysha Gene Therapies, Inc. (TSHA), a clinical-stage biotechnology company, is gaining attention in the healthcare sector with its ambitious pursuit of adeno-associated virus-based gene therapies. Headquartered in Dallas, Texas, and..
ArriVent BioPharma, Inc. (AVBP), a clinical-stage biopharmaceutical company, is making waves in the biotechnology industry with its promising pipeline of cancer therapies. With a market capitalization of $1.31 billion, ArriVent..
Spyre Therapeutics, Inc. (NASDAQ: SYRE), a promising player in the biotechnology sector, stands out with a compelling potential upside of 22.53%, catching the attention of investors seeking opportunities in the..
Simulations Plus, Inc. (NASDAQ: SLP) stands prominently in the healthcare sector, specializing in health information services. This U.S.-based company has carved a niche in the drug discovery and development sector..
Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company, is pioneering the development of oncolytic immunotherapies designed to activate the immune system against cancer. While its innovative approach to cancer..
Immunome, Inc. (NASDAQ: IMNM), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising therapeutic innovations and a robust consensus of buy ratings. With..
InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, specifically within the medical devices industry, is headquartered in Yokne’am, Israel. Known for its innovative approach to minimally invasive..
Gyre Therapeutics, Inc. (NASDAQ: GYRE) is capturing attention in the healthcare sector, particularly among biotechnology investors, due to its promising portfolio and substantial potential upside. With a market capitalization of..
Cronos Group Inc. (NASDAQ: CRON), a prominent player in the cannabinoid industry, is capturing investor attention despite a challenging market landscape. With a notable 47% revenue growth, the company is..
Geron Corporation (NASDAQ: GERN), a notable player in the biotechnology sector, offers an intriguing investment proposition with a potential upside of 101.18% according to analyst targets. With a current market..
Phibro Animal Health Corporation (NASDAQ: PAHC), a significant player in the healthcare sector, specifically in the drug manufacturing of specialty and generic products, is attracting investor attention with its robust..
In the ever-evolving biotechnology sector, Niagen Bioscience, Inc. (NASDAQ: NAGE) stands out with its innovative approach to healthy aging and a remarkable potential upside of 187.53% based on current analyst..
Investors with a keen eye on the biotechnology sector might find uniQure N.V. (NASDAQ: QURE) an intriguing prospect, particularly considering its potential upside of 129.74%. As a Dutch company specializing..
AMN Healthcare Services Inc (NYSE: AMN), a prominent player in the U.S. healthcare sector, stands at a pivotal juncture. Known for its technology-enabled workforce solutions, AMN serves a broad spectrum..
Zymeworks Inc. (ZYME), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to developing biotherapeutics for cancer, inflammation, and autoimmune diseases. With a current..
Arcus Biosciences, Inc. (NASDAQ: RCUS), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its promising pipeline of cancer therapies and a notably high..
Ardelyx, Inc. (NASDAQ: ARDX), a biotechnology company based in Waltham, Massachusetts, has captured the attention of investors with a striking potential upside of 156.37%, according to the latest analyst ratings...
